Arcturus Therapeutics Ltd (ARCT)

HEALTH CARE: PHARMACEUTICALS

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. is a clinical-stage mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR™ mRNA Technology and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus' diverse pipeline of RNA therapeutic and vaccine candidates includes mRNA vaccine programs for SARS-CoV-2 (COVID-19) and Influenza, and other programs to potentially treat Ornithine Transcarbamylase (OTC) Deficiency, and Cystic Fibrosis along with partnered programs including Glycogen Storage Disease Type 3, Hepatitis B Virus, and non-alcoholic steatohepatitis (NASH). Arcturus' versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, replicon RNA, antisense RNA, microRNA, DNA, and gene editing therapeutics. Arcturus' technologies are covered by its extensive patent portfolio (209 patents and patent applications, issued in the U.S., Europe, Japan, China and other countries). Arcturus' commitment to the development of novel RNA therapeutics has led to collaborations with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Ultragenyx Pharmaceutical, Inc., Takeda Pharmaceutical Company Limited, CureVac AG, Synthetic Genomics Inc., Duke-NUS Medical School, and the Cystic Fibrosis Foundation.

Data as of 2021-06-19 12:06:10 -0400
Market Cap923.578 Million Shares Outstanding26.32 Million Avg 30-day Volume467.314 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.87 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.34304 52-week High/Low129.71 / 24.87 Next Earnings Date2021-08-10 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 156 132 18.18% 45 (2.64%) 38 (2.21%) 18.42%
13F shares: 18.696 Million 19.84 Million -5.77% 7.48 Million 7.056 Million 6.0%
% Ownership 71.1403 81.0041 -12.18% 28.4622 28.8099 -1.21%
New Positions: 50 39 28.21% 15 15 0.0%
Increased Positions 49 52 -5.77% 16 9 77.78%
Closed Positions 26 32 -18.75% 8 15 -46.67%
Reduced Positions 40 33 21.21% 9 12 -25.0%
Total Calls 748.61 Thousand 1.171 Million -36.06% 143.5 Thousand 176.5 Thousand -18.7%
Total Puts 688.254 Thousand 898.488 Thousand -23.4% 331.5 Thousand 298.906 Thousand 10.9%
PUT/CALL Ratio 0.92 0.77 19.48% 2.31 1.69 36.69%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding ARCT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARCT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-24 16:15:03 UTC -0.3499 0.4299 150000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-24 15:45:03 UTC -0.3499 0.4299 150000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-24 15:15:03 UTC -0.3499 0.4299 150000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-24 14:45:03 UTC -0.3188 0.3988 150000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-24 14:15:02 UTC -0.3188 0.3988 150000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-24 13:45:03 UTC -0.3188 0.3988 150000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-24 13:15:02 UTC -0.3188 0.3988 150000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-24 12:45:03 UTC -0.3188 0.3988 150000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 22:15:03 UTC -0.3188 0.3988 200000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 21:45:03 UTC -0.3188 0.3988 200000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 21:15:03 UTC -0.3188 0.3988 200000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 20:45:02 UTC -0.3262 0.4062 200000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 20:15:04 UTC -0.3262 0.4062 200000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 19:45:03 UTC -0.3262 0.4062 200000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 19:15:03 UTC -0.3262 0.4062 200000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 18:45:02 UTC -0.3347 0.4147 200000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 18:15:03 UTC -0.3347 0.4147 200000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 17:45:02 UTC -0.3347 0.4147 200000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 17:15:03 UTC -0.3347 0.4147 200000
ARCTURUS THERAPEUTICS HOLDIN ARCT 2021-06-23 16:45:03 UTC -0.3486 0.4286 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio ARCT -1800.0 shares, $-74340.0 2021-03-31 N-PORT

Elevate your investments